Real-World Evidence Could Speed Development Of Drugs Offering Incremental Improvements
US FDA Commissioner Gottlieb says common diseases need new treatments and argues streamlining trials may pique industry interest.
US FDA Commissioner Gottlieb says common diseases need new treatments and argues streamlining trials may pique industry interest.